NeuBase Therapeutics announces receipt of Nasdaq noticeSeekingAlpha.com: All News • 20 days ago
NeuBase Therapeutics announces receipt of Nasdaq notice...
Share to Feed
PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ( NeuBase or the Company ) today reported that it received a notice (the Notice) on April 4, 2024 from...
Lisata Therapeutics (NASDAQ:LSTA Get Free Report) and NeuBase Therapeutics (NASDAQ:NBSE Get Free Report) are both small-cap medical companies, but which is the superior stock? We will...
Titoli in rialzo
Il titolo NeuBase Therapeutics (NASDAQ:NBSE) ha osservato un incremento del 30,52% a 0,98 dollari durante la sessione after-market di venerd .
Le azioni di Ocean Biomedical...
Acciones al alza
NeuBase Therapeutics (NASDAQ:NBSE) avanzaron un 31,85% para establecerse en los 0,99 d lares durante la sesi n del after-market del viernes.
Ocean Biomedical (NASDAQ:OCEA) subieron...
NeuBase Therapeutics, Inc. (NASDAQ:NBSE Get Free Report) shares dropped 3.3% on Thursday . The stock traded as low as $0.68 and last traded at $0.69. Approximately 37,086 shares changed hands...
Shares of NeuBase Therapeutics, Inc. (NASDAQ:NBSE Get Free Report) traded down 2.7% during trading on Tuesday . The company traded as low as $0.70 and last traded at $0.72. 84,031 shares...